UnitedHealth Group (NYSE:UNH) Updates FY 2025 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 29.500-30.000 for the period, compared to the consensus EPS estimate of 29.950. The company issued revenue guidance of $450.0 billion-$455.0 billion, compared to the consensus revenue estimate of $430.4 billion. UnitedHealth Group also updated its FY25 guidance to $29.50-$30.00 EPS.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. UBS Group cut their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $621.58.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $3.29 during trading hours on Tuesday, hitting $605.23. 2,327,488 shares of the company’s stock traded hands, compared to its average volume of 3,848,914. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $556.98 billion, a price-to-earnings ratio of 39.43, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The company’s fifty day simple moving average is $585.43 and its two-hundred day simple moving average is $556.65. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $6.56 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.